Literatur
-
1
Adler J L, Zicki R.
Winter vomiting disease.
J Infect Dis.
1969;
119
668-673
-
2
Glass R I, Noel J, Ando T. et al .
The epidemiology of enteric caliciviruses from humans: A reassessment using new diagnostics.
Infect Dis.
2000;
181
(Suppl)
S254
-
3
Gordon I, Ingraham H S, Korns R F.
Transmission of epidemic gastroenteritis to human volunteers by oral administration of fecal filtrates.
J Exp Med.
1947;
86
409-422
-
4
Jansen A, Beyer A, Brandt C, Höhne M, Schreier E, Schulzke J, Zeitz M, Schneider T.
The norovirus-epidemic in Berlin - clinic, epidemiology, and prevention.
Z Gastroenterol.
2004;
42
(4)
311-316
-
5
Johnston C P, Qiu H, Ticehurst J R. et al .
Outbreak management and implications of a nosocomial norovirus outbreak.
Clin Infect Dis.
2007;
45
(5)
534-40
, Epub 2007 Jul 18
-
6
Hutson A M, Atmar R L, Estes M E.
Norovirus diseases: changing epidemiology and host susceptibility factors.
Trends in Microbiology.
2004;
12
279-287
-
7
Kaplan J E, Feldman R, Campbell D S, Lookabaugh C, Gary G WT.
The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis.
Am J Public Health.
1982;
72
1329-1332
-
8
Kapikian A Z, Wyatt R G, Dolin R, Thornhill T S, Kalica A R, Chanock R M.
Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis.
J Virol.
1972;
10
1075-1081
-
9
Kaufman S S, Chatterjee N K, Fuschino M E.
Calicivirus enteritis in an intestinal transplant recipient.
Am J Transplant.
2003;
3
764-768
-
10
Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R.
Human susceptibility and resistance to Norwalk virus infection.
Nat Med.
2003;
9
(5)
548-553
, Epub 2003 Apr 14
-
11
LoBue A D, Lindesmith L, Yount B. et al .
Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.
Vaccine.
2006;
24
(24)
5220-5234
, Epub 2006 Apr 18
-
12
Lopman B A, Brown D W, Koopmans M.
Human caliciviruses in Europe.
J Clin Virol.
2002;
24
137-160
-
13
Lopman B, Vennema H, Kohli E.
Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.
Lancet.
2004;
363
682-689
-
14
Mead P S, Slutsker L, Dietz V. et al .
Food-related illness and death in the United States.
Emerg Infect Dis.
1999;
5
(5)
607-625
-
15
Nicollier-Jamot B, Ogier A, Piroth L, Pothier P, Kohli E.
Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2- like immune responses.
Vaccine.
2004;
12
1079-1086
-
16
Reimann H A, Price A H, Hodges J H.
The cause of epidemic diarrhea, nausea and vomiting (Viral dysentery?).
Proc Soc Exp Biol Med.
1945;
59
8-9
-
17
Schwarz S. et al .
in Vorbereitung.
-
18
Tacket C O, Sztein M B, Losonsky G A, Wasserman S S, Estes M KH.
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers.
Clin Immunol.
2003;
108
241-247
Prof. Dr. med. Thomas Schneider
Charité-Universitästsmedizin Berlin - Campus Benjamin Franklin, Medizinische Klinik I (Gastroenterologie, Infektiologie und Rheumatologie)
Phone: 030 / 8445 2286
Fax: 030 / 8445 2286
Email: thomas.schneider@charite.de
